Pfizer/BioNTech COVID-19 vaccine approved for use by UK regulator
Pfizer and BioNTech’s COVID-19 vaccine has been approved for use by the UK’s regulator, MHRA,…
Browsing: Coronavirus
What are the advantages of the Oxford—AstraZeneca COVID-19 vaccine?
While the latest set of interim vaccine results from Oxford University and AstraZeneca include an…
Antimicrobials: handle with care
World Antimicrobial Awareness Week 2020 (WAAW; 18–24 November) is upon us. Infectious Diseases Hub takes…
Moderna’s COVID-19 vaccine demonstrates 94.5% efficacy
Just 1 week after Pfizer and BioNTech’s early Phase III trial data were released, more…
Pfizer and BioNTech’s COVID-19 vaccine 90% effective in Phase III trial
The first set of data from Pfizer (NY, USA) and BioNTech’s (Mainz, Germany) Phase III…
Accelerate your COVID-19 bioanalytical research while saving time and reducing cost
Wednesday 18 November 2020 11:00 [EST] 08:00 [PST] 16:00 [GMT] Alternative time zones REGISTER NOW…
COVID-19 biomarkers identified that could diagnose and predict outcomes
Three blood metabolites have been identified by Canadian researchers that appear to be affected by COVID-19,…
What is the extent of SARS-CoV-2 immunity post-exposure?
The question of COVID-19 immunity is on everyone’s lips. It is crucial to understand how immunity…
What are the long-term effects of COVID-19 infection?
A recently published review, ‘Living with COVID’, details the most up-to-date information surrounding ongoing COVID-19…
The role of home and the community hygiene to prevent the spread of infection and reduce antimicrobial resistance in developed countries
Exploring the evidence to support the role of home and community hygiene in preventing the…